Company Filing History:
1 out of 1 
1 out of 832,812 Years Active: 2013
Title: Elvira Luongo: Innovator in Non-Steroidal Anti-Inflammatory Pro-Drugs
Introduction
Elvira Luongo, hailing from Torre le Nocelle, Italy, is a prominent inventor known for her significant contribution to the field of pharmacology. With a focus on improving the pharmacokinetic characteristics and reducing toxicity of non-steroidal anti-inflammatory drugs (NSAIDs), she has developed innovative solutions that aim to enhance patient safety and drug efficacy.
Latest Patents
Luongo's most notable patent addresses galactosylated pro-drugs of NSAIDs. This patent entails the creation of pro-drugs for various non-steroidal anti-inflammatories, including well-known medications such as aspirin, ibuprofen, and diclofenac. The pro-drugs are designed with an ester group, incorporating sugars and oligosaccharides that optimize their effectiveness while minimizing toxicity.
Career Highlights
Throughout her career, Elvira Luongo has worked with several reputable organizations. Notably, she was employed at Stewart Italia Srl, where her research and development efforts have made a lasting impact on pharmaceutical innovations. Her advancements in the field of NSAIDs highlight her dedication to enhancing medication safety and performance.
Collaborations
Collaboration has been an essential aspect of Luongo’s career. She has worked closely with esteemed colleagues such as Maria Grazia Rimoli and Antonio Calignano. Together, they have furthered research initiatives that continuously contribute to the global understanding and application of non-steroidal anti-inflammatory drugs.
Conclusion
Elvira Luongo's contributions to the pharmaceutical industry, particularly in the development of safer and more effective NSAIDs, reflect her commitment to innovation. Her patent and collaborative efforts underscore the essential role inventors play in advancing medical science and improving patient care. Luongo's work is a testament to the power of innovation in the fight against inflammation and pain, setting a standard for future research in the field.